Israeli company Brainsway Ltd. has received approval from the Health Canada for its Deep TMS treatment. The treatment, approved earlier this month by the American FDA, uses transcranial magnetic stimulation for treating people suffering from depression for whom drug treatment was not effective.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments